Results 121 to 130 of about 47,090 (208)

Targeting B7-H3 in patients with metastatic triple-negative breast cancer and brain metastases: an opportunity to "revive" immunotherapy as a treatment strategy? [PDF]

J Immunother Cancer
Kojundzic I, Zatzman C, Belone Lopes J, Ramay R, Bayani J, Spears M, Jerzak KJ.   +6 more
europepmc   +1 more source

Multifunctional HBc Virus-Like Particles Reprogram Immunosuppressive Macrophages and Potentiate CD8+ T Cell Responses for Enhanced Cancer Immunotherapy

International Journal of Nanomedicine
Shuntao Liang,1,* Xiaoxuan Yin,1,* Yongjie Chi,2,3,* Keyue Wang,1,* Li Ma,4 Zhu Yang,2,3 Xin Xue,5 Shoucheng Wang,2,6 Kai Zhao,6 Lianyan Wang,2,3 Juan Ma1 1Biomedical Innovation Center, Beijing Shijitan Hospital, Capital ...
Liang S, Yin X, Chi Y, Wang K, Ma L, Yang Z, Xue X, Wang S, Zhao K, Wang L, Ma J   +10 more
doaj  

Preclinical efficacy of combinatorial B7-H3 CAR T cells and ONC206 against diffuse intrinsic pontine glioma. [PDF]

Neuro Oncol
Timpanaro A, Song EZ, Toumi R, Elena-Sanchez L, Piccand C, Nemec KM, Kordowski A, Lau D, Johnson S, Winter L, Rajendran A, Ronsley R, Oda SK, Gustafson JA, Wendler JP, Koschmann C, Evans M, Pattwell S, Jensen MC, Foster JB, Dun MD, Meechan M, Biery MC, Vitanza NA.   +23 more
europepmc   +1 more source

Immune checkpoint inhibitors in medulloblastoma: current updates in preclinical and clinical developments. [PDF]

Front Oncol
Welch RL, Moziak K, Zang X, Martin AM.
europepmc   +1 more source

Multiple sclerosis-associated HLA demarcates EBV-specific CD8⁺ T cells with an exhausted and brain residency phenotype. [PDF]

iScience
Reijm S, Marques AM, Rip J, Corsten CEA, Wierenga-Wolf AF, de Wit H, Melief MJ, van Hasselt Y, van Langelaar J, Neuteboom R, Wokke BHA, Mueller YM, Smolders J, van Luijn MM.   +13 more
europepmc   +1 more source

Harnessing γδ T cells for B7-H3-targeting CAR therapy to enhance anti-tumor therapy in glioblastoma. [PDF]

J Transl Med
Wu H, Chen T, Yu Y, Zhu S.
europepmc   +1 more source

From mechanism to clinical: research evolution and hotspot analysis of CD276/B7-H3 in cancer immunotherapy. [PDF]

Front Immunol
Zhai C, Ye J, Li X, Liu J, Zhou X, Wang Z, Zhang X, Zeng W, Luo H, Chen L, Zhou F.   +10 more
europepmc   +1 more source

Integrated radio-theranostics using a [⁸⁹Zr]Zr-/[¹⁷⁷Lu]Lu-labeled B7-H3 antibody-drug conjugate for prostate cancer. [PDF]

Theranostics
Qiu Y, Gu T, Wang T, Mulati Y, Sun X, Yang Q, Song L, Yuan T, Fan Y, Kang L, Cai W.   +10 more
europepmc   +1 more source

Overcoming fratricide of CD86 targeting CAR-T cells by defined logic-gate CAR strategy. [PDF]

Exp Hematol Oncol
Riet T, Lennartz S, Bösing N, Prinz LF, Dähn L, Scheid C, Hallek M, Chmielewski MM.   +7 more
europepmc   +1 more source

B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile Cancer. [PDF]

Immunotargets Ther
Kielbik A, Bahlinger V, Schürch CM, Barcena ML, Vakhrusheva O, Thomas A, Tsaur I, Heitmann JS, Salih HR, Hagelstein I.   +9 more
europepmc   +1 more source